Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 01, 2023

SELL
$15.28 - $16.48 $10,696 - $11,536
-700 Reduced 31.82%
1,500 $0
Q4 2022

Feb 07, 2023

SELL
$12.42 - $15.62 $26,082 - $32,802
-2,100 Reduced 48.84%
2,200 $0
Q3 2022

Oct 25, 2022

BUY
$12.8 - $28.65 $53,760 - $120,330
4,200 Added 4200.0%
4,300 $4,000
Q2 2022

Aug 04, 2022

SELL
$13.12 - $15.03 $62,975 - $72,144
-4,800 Reduced 97.96%
100 $0
Q1 2022

Apr 14, 2022

BUY
$13.54 - $15.35 $48,744 - $55,260
3,600 Added 276.92%
4,900 $11,000
Q3 2021

Oct 26, 2021

BUY
$16.3 - $17.26 $14,670 - $15,534
900 Added 225.0%
1,300 $1,000
Q2 2021

Jul 19, 2021

BUY
$16.55 - $18.64 $6,620 - $7,456
400 New
400 $1,000
Q1 2021

Apr 26, 2021

SELL
$16.71 - $19.9 $91,905 - $109,449
-5,500 Closed
0 $0
Q1 2020

May 07, 2020

SELL
$13.02 - $20.31 $166,656 - $259,967
-12,800 Reduced 69.95%
5,500 $40,000
Q4 2019

Feb 06, 2020

BUY
$16.88 - $20.83 $33,760 - $41,660
2,000 Added 12.27%
18,300 $28,000
Q3 2019

Oct 28, 2019

BUY
$16.15 - $17.99 $4,845 - $5,396
300 Added 1.88%
16,300 $66,000
Q2 2019

Aug 09, 2019

BUY
$16.58 - $20.49 $265,280 - $327,840
16,000 New
16,000 $68,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.